TP53 and KRAS co-mutations are associated with worse outcomes in mucinous ovarian carcinomas
{{output}}
Objective: Mucinous ovarian carcinomas (mOC) often harbor unique molecular alterations differentiating them from other epithelial ovarian carcinoma subtypes. We sought to characterize the somatic genomic mutation patterns in mOC ... ...